Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses EHC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named EHC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Mark Tarr | $1,100,000 | $0 | $5,285,381 | $1,165,376 | $2,581,525 | $0 | $164,976 | $10,297,258 |
| President and Chief Executive Officer | ||||||||
| Douglas Coltharp | 750,000 | 0 | 1,982,088 | 437,007 | 1,303,800 | 0 | 48,276 | 4,521,171 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Patrick Tuer | 550,000 | 0 | 1,425,095 | 0 | 786,861 | 0 | 81,432 | 2,843,388 |
| Executive Vice President and Chief Operating Officer | ||||||||
| Patrick Darby | 625,000 | 0 | 963,693 | 212,463 | 869,200 | 0 | 11,750 | 2,682,106 |
| Executive Vice President, General Counsel and Secretary | ||||||||
| Elissa Charbonneau | 435,000 | 0 | 518,452 | 0 | 453,722 | 0 | 37,409 | 1,444,583 |
| Chief Medical Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Mark Tarr | $10,297,258 | $9,301,929 | $8,836,376 | +995,329 |
| Douglas Coltharp | 4,521,171 | 3,868,736 | 5,750,370 | +652,435 |
| Patrick Tuer | 2,843,388 | — | — | — |
| Patrick Darby | 2,682,106 | 2,558,994 | 3,167,110 | +123,112 |
| Elissa Charbonneau | 1,444,583 | 1,291,587 | 1,298,212 | +152,996 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Joan E. Herman | Director | 2026-04-15 | A | 85 | $0 | $0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-04-15 | A | 19 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-04-15 | A | 334 | 106 | 35,564 | Common | Form 4 ↗ |
| Terrance Williams | Director | 2026-04-15 | A | 27 | 0 | 0 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-04-15 | A | 27 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-04-15 | A | 9 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-04-15 | A | 17 | 0 | 0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-04-15 | A | 39 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-04-15 | A | 1 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-04-15 | A | 261 | 106 | 27,710 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-04-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Joan E. Herman | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Terrance Williams | Director | 2026-05-07 | A | 1,634 | 0 | 0 | Common | Form 4 ↗ |
| Patrick Tuer | EVP, Chief Operating Officer | 2026-05-11 | D | 682 | 105 | 71,310 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | D | 1 | 107 | 107 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | D | 27,694 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | D | 27,693 | 107 | 2,958,443 | Common | Form 4 ↗ |
| Douglas Coltharp | EVP & Chief Financial Officer | 2026-05-15 | A | 27,694 | 33 | 912,240 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-07-15 | A | 319 | 112 | 35,856 | Common | Form 4 ↗ |
| Joan E. Herman | Director | 2026-07-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Leslye G. Katz | Director | 2026-07-15 | A | 85 | 0 | 0 | Common | Form 4 ↗ |
| Cain A. Hayes | Director | 2026-07-15 | A | 4 | 0 | 0 | Common | Form 4 ↗ |
| Greg D. Carmichael | Director | 2026-07-15 | A | 29 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-07-15 | A | 11 | 0 | 0 | Common | Form 4 ↗ |
| Edward M. Christie III | Director | 2026-07-15 | A | 248 | 112 | 27,883 | Common | Form 4 ↗ |
| Terrance Williams | Director | 2026-07-15 | A | 29 | 0 | 0 | Common | Form 4 ↗ |
| Nancy M. Schlichting | Director | 2026-07-15 | A | 40 | 0 | 0 | Common | Form 4 ↗ |
| Kevin J. O'Connor | Director | 2026-07-15 | A | 19 | 0 | 0 | Common | Form 4 ↗ |
| Christopher R. Reidy | Director | 2026-07-15 | A | 21 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Patrick Darby | OTHER | 2025-03-04 | — | — | 45 | — | $212,463 |
| Patrick Tuer | RSU | 2025-05-01 | — | — | 5,984 | — | 693,785 |
| Douglas Coltharp | OTHER | 2025-03-04 | — | — | 45 | — | 437,007 |
| Elissa Charbonneau | PSU | 2025-02-20 | 2 | 20 | — | 1,939 | 193,687 |
| Elissa Charbonneau | PSU | 2025-02-20 | 1,090 | 2,908 | — | 5,816 | 324,765 |
| Mark Tarr | PSU | 2025-02-20 | 13,672 | 36,457 | — | 72,914 | 4,071,518 |
| Mark Tarr | OPTION | 2025-03-04 | — | — | 33,086 | — | 1,165,376 |
| Patrick Tuer | PSU | 2025-02-20 | 2 | 20 | — | 2,735 | 273,199 |
| Patrick Darby | PSU | 2025-02-20 | 2,493 | 6,647 | — | 13,294 | 742,337 |
| Douglas Coltharp | PSU | 2025-02-20 | 2 | 20 | — | 4,557 | 455,199 |
| Patrick Tuer | PSU | 2025-02-20 | 1,538 | 4,102 | — | 8,204 | 458,111 |
| Douglas Coltharp | PSU | 2025-02-20 | 5,127 | 13,672 | — | 27,344 | 1,526,889 |
| Patrick Darby | PSU | 2025-02-20 | 2 | 20 | — | 2,216 | 221,356 |
| Mark Tarr | PSU | 2025-02-20 | 2 | 20 | — | 12,152 | 1,213,863 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Patrick Darby | $0 | $963,693 | $0 | 100.0% |
| Patrick Tuer | 693,785 | 731,310 | 0 | 51.3% |
| Douglas Coltharp | 0 | 1,982,088 | 0 | 100.0% |
| Elissa Charbonneau | 0 | 518,452 | 0 | 100.0% |
| Mark Tarr | 0 | 5,285,381 | 1,165,376 | 81.9% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Patrick Darby | PSU | 13,294 | — | $1,411,025 |
| Patrick Tuer | PSU | 8,204 | — | 870,772 |
| Elissa Charbonneau | RSU | 991 | — | 105,185 |
| Douglas Coltharp | PSU | 37,588 | — | 3,989,591 |
| Patrick Darby | RSU | 985 | — | 104,548 |
| Douglas Coltharp | PSU | 31,486 | — | 3,341,924 |
| Elissa Charbonneau | PSU | 8,914 | — | 946,132 |
| Douglas Coltharp | RSU | 3,499 | — | 371,384 |
| Patrick Darby | RSU | 2,216 | — | 235,206 |
| Patrick Tuer | PSU | 10,254 | — | 1,088,360 |
| Patrick Tuer | RSU | 5,984 | — | 635,142 |
| Patrick Tuer | RSU | 2,735 | — | 290,293 |
| Patrick Tuer | RSU | 1,140 | — | 121,000 |
| Price | Option | 2,973,090 | 60.27 | — |
| Douglas Coltharp | RSU | 31,321 | — | 3,324,411 |
| Douglas Coltharp | PSU | 27,344 | — | 2,902,292 |
| Patrick Darby | PSU | 17,720 | — | 1,880,800 |
| Mark Tarr | RSU | 9,860 | — | 1,046,540 |
| Elissa Charbonneau | PSU | 7,468 | — | 792,654 |
| Mark Tarr | Option | 16,500 | 56.21 | — |
| Mark Tarr | Option | 33,086 | 98.45 | — |
| Patrick Darby | Option | 6,032 | 98.45 | — |
| Price | Option | 2,957,672 | 60.27 | — |
| Douglas Coltharp | Option | 9,824 | 74.2 | — |
| Douglas Coltharp | Option | 6,144 | 56.21 | — |
| Patrick Darby | Option | 5,263 | 74.2 | — |
| Patrick Darby | Option | 2,897 | 56.21 | — |
| Douglas Coltharp | RSU | 2,089 | — | 221,726 |
| Elissa Charbonneau | RSU | 1,939 | — | 205,806 |
| Patrick Darby | RSU | 1,875 | — | 199,013 |
| Mark Tarr | Option | 27,683 | 74.2 | — |
| Patrick Tuer | PSU | 11,040 | — | 1,171,786 |
| Mark Tarr | PSU | 100,946 | — | 10,714,409 |
| Mark Tarr | PSU | 88,730 | — | 9,417,802 |
| Mark Tarr | PSU | 72,914 | — | 7,739,092 |
| Patrick Darby | PSU | 16,868 | — | 1,790,370 |
| Patrick Darby | RSU | 14,774 | — | 1,568,112 |
| Mark Tarr | RSU | 12,152 | — | 1,289,813 |
| Elissa Charbonneau | PSU | 5,816 | — | 617,310 |
| Mark Tarr | RSU | 5,609 | — | 595,339 |
| Douglas Coltharp | RSU | 4,557 | — | 483,680 |
| Patrick Tuer | RSU | 2,454 | — | 260,467 |
| Elissa Charbonneau | RSU | 1,660 | — | 176,192 |
| Douglas Coltharp | Option | 12,407 | 98.45 | — |
Provide a competitive rewards program for our senior management that aligns management's interests with those of our long-term stockholders. Correlate compensation with corporate, regional and business unit outcomes by recognizing performance with appropriate levels and forms of awards
| CEO STI target (% of salary) | 135% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pay Governance |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-07 | 83,410,829 | 3,006,776 | 102,636 | 96.52% | Passed |
| 2025 | 2025-05-01 | 87,426,450 | 2,187,504 | 342,779 | 97.56% | Passed |
| 2024 | 2024-05-02 | 87,432,847 | 1,824,905 | 859,438 | 97.02% | Passed |
| 2023 | 2023-05-04 | 82,107,798 | 5,282,269 | 136,695 | 93.81% | Passed |
| 2022 | 2022-05-05 | 83,468,011 | 4,073,770 | 66,352 | 95.27% | Passed |
| 2021 | 2021-05-06 | 81,575,257 | 3,257,385 | 48,896 | 96.1% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-05-07 | 96.52%a |
| 2025 | 2025-05-01 | 97.56%b |
| 2024 | 2024-05-02 | 97.02%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Approved under the standard stated in the filing — “Under applicable Delaware law, in determining whether any stockholder proposal has received the requisite number of affirmative votes, abstentions will have the same effect as a vote against any stockholder proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 203 : 1 |
|---|---|
| CEO total compensation | $10,297,258 |
| Median employee compensation | $50,647 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Greg D. CarmichaelIndependent · Board Chair · Compensation and Human Capital | $260,000 | $165,099 | $0 | $0 | $10,112 | $435,211 |
| Leslye G. KatzIndependent · Audit · Nominating/Corporate Governance (Chair) | 130,000 | 165,099 | 0 | 0 | 32,510 | 327,609 |
| Christopher R. ReidyIndependent · Audit (Chair) · Nominating/Corporate Governance | 140,000 | 165,099 | 0 | 0 | 6,834 | 311,933 |
| Nancy M. SchlichtingIndependent · Compensation and Human Capital · Compliance/Quality of Care (Chair) | 130,000 | 165,099 | 0 | 0 | 14,474 | 309,573 |
| Joan E. HermanIndependent · Compensation and Human Capital · Compliance/Quality of Care | 110,000 | 165,099 | 0 | 0 | 32,510 | 307,609 |
| Kevin J. O'ConnorIndependent · Compensation and Human Capital (Chair) · Compliance/Quality of Care | 115,000 | 165,099 | 0 | 0 | 5,981 | 286,080 |
| Terrance WilliamsIndependent · Audit | 110,000 | 165,099 | 0 | 0 | 10,112 | 285,211 |
| Edward M. Christie IIIIndependent · Audit | 110,000 | 165,099 | 0 | 0 | 2,797 | 277,896 |
| Patricia A. MarylandIndependent · Departed during FY | 97,500 | 165,099 | 0 | 0 | 7,268 | 269,867 |
| Cain A. HayesIndependent · Compensation and Human Capital · Compliance/Quality of Care · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Mark J. TarrEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $110,000 |
|---|---|
| Annual equity retainer | $165,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 30,000 / 20,000 / 20,000 |
| Stock ownership guideline | $550,000 |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,202,500 |
| Equity awards (grant-date value) | $1,485,891 |
| All other compensation | $122,598 |
| Total cost of the board | $2,810,989 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Encompass Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Encompass Health.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Labcorp Holdings | 2025 | Adam Schechter | $1,435,000 | $11,400,463 | $2,754,582 | $2,062,095 | $18,339,913 |
| 2 | DaVita | 2025 | Javier Rodriguez | 1,500,000 | 11,442,481 | 2,699,982 | 2,089,491 | 18,210,597 |
| 3 | Universal Health Services | 2025 | Marc Miller | 1,430,769 | 9,999,904 | 0 | 4,292,307 | 16,148,937 |
| 4 | Quest Diagnostics | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 5 | R1 RCM | 2023 | Lee Rivas | 900,000 | 12,240,021 | 0 | 1,015,200 | 14,159,376 |
| 6 | Ensign Group | 2025 | Barry Port | 549,264 | 2,912,355 | 0 | 10,317,247 | 13,804,700 |
| 7 | Chemed | 2025 | Kevin McNamara | 1,862,837 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 8 | Alignment Healthcare | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 9 | AMN Healthcare | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 10 | Encompass Health | 2025 | Mark Tarr | 1,100,000 | 5,285,381 | 1,165,376 | 2,581,525 | 10,297,258 |
| 11 | Option Care Health | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 12 | Acadia Healthcare | 2025 | Christopher Hunter | 1,061,000 | 5,712,012 | 0 | 1,135,270 | 7,909,463 |
| 13 | Surgery Partners | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 14 | Agilon health | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 15 | Brookdale Senior Living | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 16 | Select Medical Holdings | 2025 | Thomas Mullin | 618,000 | 1,425,000 | 0 | 939,360 | 3,042,527 |
| — | Amedisys | — | — | — | — | — | — | not in coverage universe |
| — | PACS Group | — | — | — | — | — | — | not in coverage universe |
| — | BrightSpring Health Services | — | — | — | — | — | — | not in coverage universe |
| — | Community Health Systems | — | — | — | — | — | — | not in coverage universe |
| — | ModivCare | — | — | — | — | — | — | not in coverage universe |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Encompass Health | 173.8% | PSU 60 · RSU 20 · Options 20 | No | Pay Governance |
| Acadia Healthcare | 85.6% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| Agilon health | 58% | RSU 50 · Options 50 | No | Semler Brossy |
| Alignment Healthcare | 200% | RSU 50 · PSU 50 | No | FW Cook |
| Amedisys | not disclosed | not disclosed | not disclosed | not disclosed |
| AMN Healthcare | 87% | PSU 65 · RSU 35 | Yes — Relative TSR | FW Cook |
| BrightSpring Health Services | not disclosed | not disclosed | not disclosed | not disclosed |
| Brookdale Senior Living | 125.7% | PSU 60 · RSU 40 | No | F.W. Cook & Co., Inc. |
| Chemed | 60.4% | not disclosed | Yes — 3-Year Relative TSR | Compensation Strategies, Inc. |
| Community Health Systems | not disclosed | not disclosed | not disclosed | not disclosed |
| DaVita | 93% | PSU 60 · RSU 20 · Options 20 | Yes — Relative TSR v. S&P Health Care Services Select Industry Index | Compensia |
| Ensign Group | not disclosed | not disclosed | not disclosed | Willis Towers Watson |
| Labcorp Holdings | 95.8% | PSU 60 · RSU 20 · Options 20 | Yes — RELATIVE TSR MODIFIER | FW Cook |
| ModivCare | not disclosed | not disclosed | not disclosed | not disclosed |
| Option Care Health | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| PACS Group | not disclosed | not disclosed | not disclosed | not disclosed |
| Quest Diagnostics | not disclosed | not disclosed | not disclosed | Semler Brossy |
| R1 RCM | 94% | PSU 75 · RSU 25 | No | SullivanCotter |
| Select Medical Holdings | 190% | RSU 100 | not disclosed | not disclosed |
| Surgery Partners | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| Universal Health Services | 200% | RSU 50 · PSU 50 | No | FW Cook |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Mark Tarr | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Summary Compensation Table” · page 49. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480 |
| 2 | Section 01, Douglas Coltharp | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Summary Compensation Table” · page 49. As printed: 4,521,171. Filing ↗machine: r8 · c48 · span 749784–749793 |
| 3 | Section 01, Patrick Tuer | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Summary Compensation Table” · page 49. As printed: 2,843,388. Filing ↗machine: r5 · c48 · span 744804–744813 |
| 4 | Section 01, Patrick Darby | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Summary Compensation Table” · page 49. As printed: 2,682,106. Filing ↗machine: r11 · c48 · span 759299–759308 |
| 5 | Section 01, Elissa Charbonneau | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Summary Compensation Table” · page 49. As printed: 1,444,583. Filing ↗machine: r14 · c48 · span 768121–768130 |
| 6 | Section 03, Patrick Darby OTHER | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r37 · c7 · span 1036109–1036111 |
| 7 | Section 03, Patrick Tuer RSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r16 · c12 · span 986149–986154 |
| 8 | Section 03, Douglas Coltharp OTHER | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r27 · c7 · span 1012654–1012656 |
| 9 | Section 03, Elissa Charbonneau PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r41 · c12 · span 1045105–1045110 |
| 10 | Section 03, Elissa Charbonneau PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r12 · c7 · span 796786–796793 |
| 11 | Section 03, Mark Tarr PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r2 · c7 · span 781184–781193 |
| 12 | Section 03, Mark Tarr OPTION | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r11 · c4 · span 974330–974336 |
| 13 | Section 03, Patrick Tuer PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t61 · r3 · c5 · span 807288–807290 |
| 14 | Section 03, Patrick Darby PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r9 · c7 · span 792512–792519 |
| 15 | Section 03, Douglas Coltharp PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t53 · r5 · c4 · span 650770–650772 |
| 16 | Section 03, Patrick Tuer PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r5 · c7 · span 786066–786073 |
| 17 | Section 03, Douglas Coltharp PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r6 · c7 · span 787740–787749 |
| 18 | Section 03, Patrick Darby PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t53 · r6 · c4 · span 652264–652266 |
| 19 | Section 03, Mark Tarr PSU | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t53 · r3 · c4 · span 647607–647609 |
| 20 | Section 07, pay ratio | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “CEO Pay Ratio”. As printed: 203 : 1. Filing ↗machine: span 1110243–1110248 |
| 21 | Section 08, Greg D. Carmichael | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 435,211. Filing ↗machine: t24 · r2 · c10 · span 386533–386540 |
| 22 | Section 08, Leslye G. Katz | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 327,609. Filing ↗machine: t24 · r6 · c10 · span 392842–392849 |
| 23 | Section 08, Christopher R. Reidy | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 311,933. Filing ↗machine: t24 · r9 · c10 · span 397635–397642 |
| 24 | Section 08, Nancy M. Schlichting | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 309,573. Filing ↗machine: t24 · r10 · c10 · span 399165–399172 |
| 25 | Section 08, Joan E. Herman | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 307,609. Filing ↗machine: t24 · r5 · c10 · span 391317–391324 |
| 26 | Section 08, Kevin J. O'Connor | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 286,080. Filing ↗machine: t24 · r8 · c10 · span 396106–396113 |
| 27 | Section 08, Terrance Williams | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 285,211. Filing ↗machine: t24 · r11 · c10 · span 400692–400699 |
| 28 | Section 08, Edward M. Christie III | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 277,896. Filing ↗machine: t24 · r3 · c10 · span 388064–388071 |
| 29 | Section 08, Patricia A. Maryland | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 269,867. Filing ↗machine: t24 · r7 · c10 · span 394574–394581 |
| 30 | Section 08, Cain A. Hayes | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 0. Filing ↗machine: t24 · r4 · c10 · span 389680–389681 |
| 31 | Section 08, Mark J. Tarr | DEF 14A | 2026-04-07 | 0000785161-26-000105 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 32 | Section 02, Joan E. Herman 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000119 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Christopher R. Reidy 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Christopher R. Reidy 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000113 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Terrance Williams 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000109 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Greg D. Carmichael 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000125 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Edward M. Christie III 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000123 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Kevin J. O'Connor 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000115 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Nancy M. Schlichting 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000111 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Cain A. Hayes 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000121 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Edward M. Christie III 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000123 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Leslye G. Katz 2026-04-15 | Form 4 | 2026-04-16 | 0000785161-26-000117 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Christopher R. Reidy 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000144 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Cain A. Hayes 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000142 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Greg D. Carmichael 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000140 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Leslye G. Katz 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000136 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Joan E. Herman 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000134 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Nancy M. Schlichting 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000132 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Kevin J. O'Connor 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000148 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Edward M. Christie III 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000146 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Terrance Williams 2026-05-07 | Form 4 | 2026-05-11 | 0000785161-26-000138 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Patrick Tuer 2026-05-11 | Form 4 | 2026-05-12 | 0000785161-26-000153 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Douglas Coltharp 2026-05-15 | Form 4 | 2026-05-18 | 0000785161-26-000158 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Douglas Coltharp 2026-05-15 | Form 4 | 2026-05-18 | 0000785161-26-000158 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Douglas Coltharp 2026-05-15 | Form 4 | 2026-05-18 | 0000785161-26-000158 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Douglas Coltharp 2026-05-15 | Form 4 | 2026-05-18 | 0000785161-26-000158 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Christopher R. Reidy 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000180 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Joan E. Herman 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000168 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Leslye G. Katz 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000170 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Cain A. Hayes 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000166 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Greg D. Carmichael 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000164 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Edward M. Christie III 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000178 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Edward M. Christie III 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000178 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Terrance Williams 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000176 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Nancy M. Schlichting 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000174 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Kevin J. O'Connor 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000172 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Christopher R. Reidy 2026-07-15 | Form 4 | 2026-07-16 | 0000785161-26-000180 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 06, 2026 vote | Form 8-K | 2026-05-11 | 0000785161-26-000151 | Item 5.07 · say-on-pay result. As reported: 96.52% (votes for as printed: 83,410,829). Filing ↗ |
| 69 | Section 06, 2025 vote | Form 8-K | 2025-05-02 | 0000785161-25-000025 | Item 5.07 · say-on-pay result. As reported: 97.56% (votes for as printed: 87,426,450). Filing ↗ |
| 70 | Section 06, 2024 vote | Form 8-K | 2024-05-06 | 0000785161-24-000031 | Item 5.07 · say-on-pay result. As reported: 97.02% (votes for as printed: 87,432,847). Filing ↗ |
| 71 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 72 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 73 | Section 09b board cost (computed) | Computed | — | computed | Cash 1,202,500 + equity 1,485,891 + all other 122,598 = 2,810,989, summed across the director compensation table rows.machine: formula: Σ = 2,810,989 |
| 74 | Labcorp Holdings, Section 10b CEO total | DEF 14A | 2026-04-10 | 0001193125-26-150752 | CEO total compensation as printed in Labcorp Holdings's own proxy. As printed: 18,339,913. Filing ↗machine: t153 · r3 · c22 · span 3147696–3147706 |
| 75 | DaVita, Section 10b CEO total | DEF 14A | 2026-04-22 | 0000927066-26-000053 | CEO total compensation as printed in DaVita's own proxy. As printed: 18,210,597. Filing ↗machine: r2 · c45 · span 800715–800725 |
| 76 | Universal Health Services, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001193125-26-148814 | CEO total compensation as printed in Universal Health Services's own proxy. As printed: 16,148,937. Filing ↗machine: span 1326856–1326866 |
| 77 | Quest Diagnostics, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013356 | CEO total compensation as printed in Quest Diagnostics's own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337 |
| 78 | R1 RCM, Section 10b CEO total | DEF 14A | 2024-04-12 | 0001628280-24-015923 | CEO total compensation as printed in R1 RCM's own proxy. As printed: 14,159,376. Filing ↗machine: span 758069–758079 |
| 79 | Ensign Group, Section 10b CEO total | DEF 14A | 2026-04-02 | 0001125376-26-000014 | CEO total compensation as printed in Ensign Group's own proxy. As printed: 13,804,700. Filing ↗machine: span 521316–521326 |
| 80 | Chemed, Section 10b CEO total | DEF 14A | 2026-04-09 | 0001562762-26-000052 | CEO total compensation as printed in Chemed's own proxy. As printed: 12,904,720. Filing ↗machine: t18 · r8 · c8 · span 1091846–1091856 |
| 81 | Alignment Healthcare, Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027058 | CEO total compensation as printed in Alignment Healthcare's own proxy. As printed: 11,278,583. Filing ↗machine: r2 · c21 · span 656828–656838 |
| 82 | AMN Healthcare, Section 10b CEO total | DEF 14A | 2026-03-18 | 0001104659-26-029908 | CEO total compensation as printed in AMN Healthcare's own proxy. As printed: 10,669,780. Filing ↗machine: t94 · r1 · c42 · span 1287064–1287074 |
| 83 | Encompass Health (subject), Section 10b CEO total | DEF 14A | 2026-04-07 | 0000785161-26-000105 | CEO total compensation as printed in Encompass Health's own proxy. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480 |
| 84 | Option Care Health, Section 10b CEO total | DEF 14A | 2026-04-08 | 0001140361-26-013825 | CEO total compensation as printed in Option Care Health's own proxy. As printed: 9,266,330. Filing ↗machine: r2 · c25 · span 1114074–1114083 |
| 85 | Acadia Healthcare, Section 10b CEO total | DEF 14A | 2026-03-25 | 0001140361-26-011130 | CEO total compensation as printed in Acadia Healthcare's own proxy. As printed: 7,909,463. Filing ↗machine: t159 · r1 · c27 · span 558066–558075 |
| 86 | Surgery Partners, Section 10b CEO total | DEF 14A | 2026-04-23 | 0001638833-26-000039 | CEO total compensation as printed in Surgery Partners's own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872 |
| 87 | Agilon health, Section 10b CEO total | DEF 14A | 2026-04-22 | 0001628280-26-026544 | CEO total compensation as printed in Agilon health's own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326 |
| 88 | Brookdale Senior Living, Section 10b CEO total | DEF 14A | 2026-04-30 | 0001193125-26-197412 | CEO total compensation as printed in Brookdale Senior Living's own proxy. As printed: 5,307,655. Filing ↗machine: t227 · r4 · c27 · span 1161767–1161776 |
| 89 | Select Medical Holdings, Section 10b CEO total | DEF 14A | 2026-03-04 | 0001104659-26-023205 | CEO total compensation as printed in Select Medical Holdings's own proxy. As printed: 3,042,527. Filing ↗machine: r13 · c41 · span 384685–384694 |
| 90 | Section 10a, Alignment Healthcare reciprocity | DEF 14A | — | 0001628280-26-027058 | Alignment Healthcare's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗ |
| 91 | Section 10a, Brookdale Senior Living reciprocity | DEF 14A | — | 0001193125-26-197412 | Brookdale Senior Living names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 92 | Section 10a, Ensign Group reciprocity | DEF 14A | — | 0001125376-26-000014 | Ensign Group names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 93 | Section 10a, Quest Diagnostics reciprocity | DEF 14A | — | 0001140361-26-013356 | Quest Diagnostics's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗ |
| 94 | Section 10a, R1 RCM reciprocity | DEF 14A | — | 0001628280-24-015923 | R1 RCM's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗ |
| 95 | Section 10a, DaVita reciprocity | DEF 14A | — | 0000927066-26-000053 | DaVita names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 96 | Section 10a, Surgery Partners reciprocity | DEF 14A | — | 0001638833-26-000039 | Surgery Partners names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 97 | Section 10a, Universal Health Services reciprocity | DEF 14A | — | 0001193125-26-148814 | Universal Health Services names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 98 | Section 10a, Chemed reciprocity | DEF 14A | — | 0001562762-26-000052 | Chemed names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 99 | Section 10a, Agilon health reciprocity | DEF 14A | — | 0001628280-26-026544 | Agilon health's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗ |
| 100 | Section 10a, AMN Healthcare reciprocity | DEF 14A | — | 0001104659-26-029908 | AMN Healthcare names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 101 | Section 10a, Acadia Healthcare reciprocity | DEF 14A | — | 0001140361-26-011130 | Acadia Healthcare names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 102 | Section 10a, Labcorp Holdings reciprocity | DEF 14A | — | 0001193125-26-150752 | Labcorp Holdings's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗ |
| 103 | Section 10a, Option Care Health reciprocity | DEF 14A | — | 0001140361-26-013825 | Option Care Health names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗ |